Breast MRI Screening Market

By Product Type;

Closed Systems and Open Systems

By Technology;

Ionizing and Non-ionizing

By Magnetic Field Strength;

Low Field Strength, Mid Field Strength, and High Field Strength

By End User;

Hospitals, Cancer Research Centers, Speciality Clinics, and Diagnostic Laboratories

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn109266446 Published Date: June, 2025 Updated Date: July, 2025

Breast MRI Screening Market Overview

Breast MRI Screening Market (USD Million)

In the year 2024, the Global Breast MRI Screening et Market was valued at USD 3233.57 million in the year 2024. The size of this market is expected to increase to USD 6798.55 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.2%.


Breast MRI Screening Market

*Market size in USD million

CAGR 11.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)11.2 %
Market Size (2024)USD 3233.57 Million
Market Size (2031)USD 6798.55 Million
Market ConcentrationLow
Report Pages372
3233.57
2024
6798.55
2031

Major Players

  • Hologic
  • Siemens
  • Fujifilm Holdings
  • GE
  • Philips
  • Aurora Imaging Technology
  • SonoCiné
  • Gamma Medica

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Breast MRI Screening Market

Fragmented - Highly competitive market without dominant players


The Breast MRI Screening Market is expanding steadily due to rising awareness about early detection of breast cancer and the limitations of standard imaging methods. Women at high risk are increasingly choosing breast MRI as an additional screening option, with about 35% now using it alongside mammography to enhance detection precision. The market's momentum is rooted in a stronger focus on accurate and early diagnostic outcomes.

Innovation Enhances Imaging Accuracy
Recent advancements in MRI technology have drastically improved detection capabilities, especially in women with dense breast tissue. Over 50% of MRI systems are now equipped with sophisticated contrast protocols, providing enhanced clarity and precision. This has made MRI a preferred option in cases where traditional imaging techniques fail to deliver reliable results, fueling adoption across diagnostic centers.

Awareness and Preventive Care Uptake
Rising public consciousness about breast health is transforming patient behavior, with 45% of women now opting for MRI screening following inconclusive mammograms. This trend aligns with the growing preference for preventive healthcare approaches, where individuals proactively manage their health risks. This shift is significantly contributing to the expansion of the breast MRI screening landscape.

AI Integration Drives Diagnostic Efficiency
The application of AI and machine learning in breast MRI interpretation is transforming the diagnostic process. Over 30% of modern MRI units now utilize AI-based tools to identify suspicious lesions with improved accuracy. These innovations are helping radiologists reduce false positives and make faster, more informed decisions, ultimately enhancing the clinical value of breast MRI screenings.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Magnetic Field Strength
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Breast MRI Screening Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. MRI Technology Advancements
        2. Increased Breast Cancer Rates
        3. Awareness Campaigns
        4. MRI's Advantages Over Mammography
        5. Patient Preference for Non-invasive Methods
      2. Restraints
        1. Limited MRI Facility Access
        2. Reimbursement Challenges
        3. Result Interpretation Complexity
        4. Patient Anxiety
      3. Opportunities
        1. Telemedicine Adoption
        2. Patient-Centered Care
        3. AI & Machine Learning Integration
        4. Screening Program Expansion
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Breast MRI Screening Market, By Product Type, 2021 - 2031 (USD Million)
      1. Closed Systems
      2. Open Systems
    2. Breast MRI Screening Market, By Technology, 2021 - 2031 (USD Million)

      1. Ionizing

      2. Non-ionizing

    3. Breast MRI Screening Market, By Magnetic Field Strength, 2021 - 2031 (USD Million)
      1. Low Field Strength
      2. Mid Field Strength
      3. High Field Strength
    4. Breast MRI Screening Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Cancer Research Centers
      3. Specialty Clinics
      4. Diagnostic Laboratories
    5. Breast MRI Screening Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Hologic
      2. Siemens
      3. Fujifilm Holdings
      4. GE
      5. Philips
      6. Aurora Imaging Technology
      7. SonoCiné
      8. Gamma Medica
  7. Analyst Views
  8. Future Outlook of the Market